Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Department of Clinical Nutrition, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Can J Gastroenterol Hepatol. 2022 Apr 30;2022:8235736. doi: 10.1155/2022/8235736. eCollection 2022.
The purpose of this study is to analyze the effect of preoperative waiting time on the short-term outcomes and prognosis in colorectal cancer (CRC) patients.
We retrospectively analyzed 3744 CRC patients who underwent primary CRC surgery at a single clinical medical center from Jan 2011 to Jan 2020. The baseline information, short-term outcomes, overall survival (OS), and disease-free survival (DFS) were compared among the short-waiting group, the intermediate-waiting group, and the long-waiting group.
A total of 3744 eligible CRC patients were enrolled for analysis. There were no significant differences in all of the baseline information and short-term outcomes among the three groups. In multivariate analysis, older age (OS: =0.000, HR = 1.947, 95% CI = 1.631-2.324; DFS: =0.000, HR = 1.693, 95% CI = 1.445-1.983), advanced clinical stage (OS: =0.000, HR = 1.301, 95% CI = 1.161-1.457; DFS: =0.000, HR = 1.262, 95% CI = 1.139-1.400), overall complications (OS: =0.000, HR = 1.613, 95% CI = 1.303-1.895; DFS: =0.000, HR = 1.560, 95% CI = 1.312-1.855), and major complications (OS: =0.001, HR = 1.812, 95% CI = 1.338-2.945; DFS: =0.006, HR = 1.647, 95% CI = 1.153-2.352) were independent factors of OS and DFS. In addition, no significant difference was found in all stages (OS, =0.203; DFS, =0.108), stage I (OS, =0.419; DFS, =0.579), stage II (OS, =0.465; DFS, =0.385), or stage III (OS, =0.539; DFS, =0.259) in terms of OS and DFS among the three groups.
Preoperative waiting time did not affect the short-term outcomes or prognosis in CRC patients.
本研究旨在分析术前等待时间对结直肠癌(CRC)患者短期结局和预后的影响。
我们回顾性分析了 2011 年 1 月至 2020 年 1 月期间在一家临床医疗中心接受原发性 CRC 手术的 3744 例 CRC 患者。比较了短等待组、中等待组和长等待组之间的基线信息、短期结局、总生存期(OS)和无病生存期(DFS)。
共纳入 3744 例符合条件的 CRC 患者进行分析。三组间所有基线信息和短期结局均无显著差异。多因素分析显示,年龄较大(OS:=0.000,HR=1.947,95%CI=1.631-2.324;DFS:=0.000,HR=1.693,95%CI=1.445-1.983)、临床分期较晚(OS:=0.000,HR=1.301,95%CI=1.161-1.457;DFS:=0.000,HR=1.262,95%CI=1.139-1.400)、总并发症(OS:=0.000,HR=1.613,95%CI=1.303-1.895;DFS:=0.000,HR=1.560,95%CI=1.312-1.855)和主要并发症(OS:=0.001,HR=1.812,95%CI=1.338-2.945;DFS:=0.006,HR=1.647,95%CI=1.153-2.352)是 OS 和 DFS 的独立影响因素。此外,在所有分期(OS,=0.203;DFS,=0.108)、I 期(OS,=0.419;DFS,=0.579)、II 期(OS,=0.465;DFS,=0.385)和 III 期(OS,=0.539;DFS,=0.259)中,三组间 OS 和 DFS 均无显著差异。
术前等待时间并不影响 CRC 患者的短期结局或预后。